scispace - formally typeset
S

Sébastien Vidal

Researcher at Claude Bernard University Lyon 1

Publications -  162
Citations -  5018

Sébastien Vidal is an academic researcher from Claude Bernard University Lyon 1. The author has contributed to research in topics: Glycogen phosphorylase & Lectin. The author has an hindex of 35, co-authored 159 publications receiving 4476 citations. Previous affiliations of Sébastien Vidal include University of California, Los Angeles & University of Montpellier.

Papers
More filters
Journal ArticleDOI

Variations on the SnCl4 and CF3CO2Ag-promoted glycosidation of sugar acetates: a direct, versatile and apparently simple method with either α or β stereocontrol

TL;DR: 1,2-trans-glycosides, expected from acyl-protected glycosyl donors, were formed in high yields with alcohols sharing specific features such as bulkiness, presence of electron-withdrawing groups or polyethoxy motifs.
Journal ArticleDOI

Pentavalent pillar[5]arene-based glycoclusters and their multivalent binding to pathogenic bacterial lectins

TL;DR: Binding to the fucose-selective lectins confirmed the importance of topology of the glycoclusters for activity with the pillar[5]arene ligand proving a selective ligand for BambL.
Journal ArticleDOI

Synthesis of lactosylated glycoclusters and inhibition studies with plant and human lectins.

TL;DR: A difference in the inhibitory properties based on two techniques confirmed the need for multiple complementary analyses for in-depth and accurate analysis of the inhibitories properties of multivalent glycoconjugates to multivalent lectins.
Journal ArticleDOI

Selective hydrogenation of acetophenone on chromium promoted raney nickel catalysts: II. Catalytic properties in the hydrogenation of acetophenone, determination of the reactivity ratios as selectivity criteria

TL;DR: In this paper, the hydrogenation of acetophenone has been investigated in cyclohexane, with chromium promoted Raney nickel catalysts and the physicico-chemical properties of these catalysts have been described.
Journal ArticleDOI

Glucose-based spiro-heterocycles as potent inhibitors of glycogen phosphorylase

TL;DR: The 2-naphthyl-substituted 1,4,2-oxathiazole displayed the best inhibition against RMGPb (K(i)=160 nM), among glucose-based inhibitors known to date, among glucopyranosylidene-spiro-1,2,4-oxadiazolines.